Skip to content

Randomized Controlled Trial (RCT) Umbilical Hernia Repair (UHR) Absorbable vs Non-absorbable Synthetic Mesh

Absorbable and Synthetic Mesh: A Multicenter, Prospective, Non-Inferior, Randomized Controlled Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05994248
Enrollment
0
Registered
2023-08-16
Start date
2025-03-31
Completion date
2029-06-30
Last updated
2025-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Umbilical Hernia

Keywords

Randomized Controlled Trial (RCT), Absorbable Mesh, Non-Absorbable Mesh

Brief summary

The goal of this study is to see which of two types of mesh is better for fixing an umbilical hernia. One type of mesh is an absorbable synthetic mesh, which goes away on its own in the body, and the other type of mesh is a non-absorbable mesh, which stays in the body forever. The researchers will check if the hernia comes back, how it affects the patient's quality of life, and if there are any problems after the surgery during a three-year period.

Detailed description

The goal of this study is to compare the use of absorbable synthetic (AS) mesh versus non-absorbable mesh (NAS) mesh to determine the 3-year recurrence, quality of life (QOL) and postoperative complications in umbilical hernia repair. Patients will be randomized into one of two arms to receive an absorbable (Enform) mesh or non-absorbable (Marlex) mesh. Patients will undergo an umbilical hernia repair with the mesh assigned to their randomization cohort. The hernia recurrence, quality of life and postoperative outcomes to determine if the two meshes are non-inferior.

Interventions

DEVICEEnform Mesh

Use of absorbable mesh in umbilical hernia repair

DEVICEMarlex

Use of non-absorbable mesh in umbilical hernia repair

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years and older * Primary umbilical hernia repair (UHR) \[as defined by European Hernia Society (EHS) guidelines primary midline abdominal wall defect from 3 cm above to 3 cm below the umbilicus\] * Undergoing elective laparoscopic or open repair * Defect size of 1-4cm2 * Centers for Disease Control and Prevention (CDC) class 1 & 2 wounds

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Umbilical Hernia Recurrence3-years postoperativelyThe rate of hernia recurrence 3-years postoperatively

Secondary

MeasureTime frameDescription
Mesh Related Complication - Mesh excision1-year postoperativelyThe rate of mesh excision within 1-year postoperatively
Postoperative Outcome - 30-day readmission30-days postoperativelyThe rate of 30-day readmission
Postoperative Outcome - Seroma3-years postoperativelyThe rate seroma within 3-years postoperatively
Postoperative Outcome - Hematoma3-years postoperativelyThe rate of hematoma within 3-years postoperatively
Postoperative Outcomes - Intra-abdominal abscess3-years postoperativelyThe rate of intra-abdominal abscess within 3-years postoperatively
Mesh Related Complication - Mesh infection1-year postoperativelyThe rate of mesh infection within 1-year postoperatively
Postoperative Outcome - Wound infection3-years postoperativelyThe rate of wound infection within 3-years postoperatively
Postoperative Outcome - Superficial wound breakdown3-years postoperativelyThe rate of superficial wound breakdown within 3-years postoperatively
Postoperative Outcomes - Mortality3-years postoperativelyThe rate of mortality within 3-years postoperatively
Postoperative Outcomes - Length of stay3-years postoperativelyThe length of stay (LOS) in the hospital postoperatively
Quality of Life (QOL)3-years postoperativelyQOL within 3-years of surgery as measured by the Carolinas Comfort Scale (CCS), a validated hernia specific QOL questionnaire. The CCS has 23 questions across 3 domains (mesh sensation, pain, and movement) that are scored 0-5 and N/A. Higher scores indicate worse symptoms. A score of 2 or more in any category is considered symptomatic; a score of 0 or 1 is considered asymptomatic. Data will be reported as the frequency and percentage of symptomatic or asymptomatic for each of the 3 domains.
Postoperative Outcome - Wound cellulitis3-years postoperativelyThe rate of wound cellulitis within 3-years postoperatively

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026